| Karen Annette Kennedy, | |
|
545 Airport Rd Ste 101, Bluefield, WV 24701-7388 | |
| (304) 325-0066 | |
| (304) 325-0077 |
| Full Name | Karen Annette Kennedy |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 545 Airport Rd Ste 101, Bluefield, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659062073 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 65363 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Annette Kennedy, 545 Airport Rd Ste 101, Bluefield, WV 24701-7388 Ph: (304) 325-0066 | Karen Annette Kennedy, 545 Airport Rd Ste 101, Bluefield, WV 24701-7388 Ph: (304) 325-0066 |
News Archive
A team of researchers from Case Western Reserve University School of Medicine have identified a mechanism that can prevent the normal prion protein from changing its molecular shape into the abnormal form responsible for neurodegenerative diseases. This finding, published in the July 18 issue of Cell Reports, offers new hope in the battle against a foe that until now has always proved fatal.
HealthEast Mental Health and Addiction Services premier program is the beneficiary of an $800,000 charitable gift by V.K. Arrigoni Foundation. This generous gift gives chemically dependent patients, without insurance or who are underinsured, access to the HealthEast inpatient services at St. Joseph's Hospital in downtown St. Paul and outpatient services at both St. Joseph's Hospital and St. John's Hospital in Maplewood.
Women under chronic stress have significantly lower levels of klotho, a hormone that regulates aging and enhances cognition, researchers at UC San Francisco have found in a study comparing mothers of children on the autism spectrum to low-stress controls.
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
Today's headlines include reports that the Obama administration will extend the deadline for signing up for insurance through healthcare.gov.
› Verified 7 days ago
Sarah M Weber, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 545 Airport Rd Ste 101, Bluefield, WV 24701 Phone: 304-320-3733 | |
Jessica Lynn Harris, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 545 Airport Rd Ste 101, Bluefield, WV 24701 Phone: 304-325-0066 | |
Shona Dobbs, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 545 Airport Rd Ste 101, Bluefield, WV 24701 Phone: 304-325-0066 | |
Angela Sluss, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1027 Frederick St, Bluefield, WV 24701 Phone: 276-970-2075 | |
Ms. Tonyi Brook Burress, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 704 Bland St Ste 507, Bluefield, WV 24701 Phone: 304-327-5530 | |
Christopher Lewis Slade, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 545 Airport Rd Ste 101, Bluefield, WV 24701 Phone: 130-432-5006 |